Vaishnavi Kambhampati
Hyderabad, TG 500007, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Gymnemagenin-3-O-glucuronide mitigates lipopolysaccharide-induced acute lung inflammation/injury by regulating the NF-κB/MAPK signalling.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 29, 2025
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: October 06, 2025
Hydronidone Mitigates Pulmonary Fibrosis by Regulating the TGF-β/Smad2/3 Axis in in Vitro and in Vivo Models.
Journal: ACS pharmacology & translational science
Published: April 30, 2025
Design and Synthesis of Novel Pirfenidone Analogues for Targeting Fibroblast Differentiation via Transforming Growth Factor-β/Smad Pathway Using In Vitro and In Vivo Models.
Journal: ACS pharmacology & translational science
Published: April 16, 2025
NARI-29: A Novel Epalrestat Derivative Attenuates Pulmonary Fibrosis by Modulating the TGF-β/Smad Signaling.
Journal: ACS pharmacology & translational science
Published: January 04, 2025
Yohimbine treatment improves pulmonary fibrosis by attenuating the inflammation and oxidative stress via modulating the MAPK pathway.
Journal: Biochemical pharmacology
Published: July 17, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026